President Trump Made Remarks at Drug Pricing Event
The president spoke about his family during a gathering to announce a nationwide Medicaid drug pricing program.
Updated on Sept. 18, 2026 in International Relations
President Donald Trump made a crude remark regarding First Lady Melania Trump during an Oval Office event held on Friday. The event was focused on announcing that all 50 states will participate in a program designed to lower Medicaid drug prices.
Why it matters
The comments were made alongside the announcement of a significant policy expansion involving state participation in federal pharmaceutical pricing initiatives. The event also included the participation of Robert F. Kennedy Jr. and Mehmet Oz.
The president announced that all 50 states have agreed to join a new program intended to reduce Medicaid drug prices. The extent of the price reductions remains subject to ongoing administrative implementation.
The players
President Donald Trump
He is the current President of the United States.
Melania Trump
She serves as the First Lady of the United States.
Robert F. Kennedy Jr.
He is a political figure who attended the Oval Office event.
Mehmet Oz
He is a public figure who attended the Oval Office event.
The details
During the Oval Office event, the president also repeated a story involving a teleprompter operator who was allegedly banned from a room. He further described his actions while standing on a stopped escalator, an anecdote he previously shared during a February 2026 meeting of his Board of Peace.
Timeline
September 18, 2026: The president made the remarks during an Oval Office event.
February 2026: The president told a similar story regarding an escalator at a meeting.
September 23, 2025: President Trump gave a speech at the United Nations General Assembly where a teleprompter operator was allegedly banned.
Political Context
Opponents have frequently criticized the administration's use of executive events to blend personal anecdotes with significant policy rollouts. These critics argue that such framing detracts from the substantive legislative or regulatory details of the programs being presented.
The expansion of the drug pricing program to all 50 states aims to lower prescription costs for Medicaid beneficiaries nationwide. Residents should monitor their state health departments for specific information on how these pricing changes may affect their local coverage.
The takeaway
The event highlights the intersection of personal rhetoric and high-level government policy announcements. Observers should track the implementation of the new drug pricing program to determine the actual impact on healthcare costs.
Further reading
For more information on national policies, visit the International Relations section.
